GLENMARK

Glenmark Pharmaceuticals Shareholding Pattern

₹2,286.10-1.08%
Market cap
₹64,514 crore
P/E
35.9
P/B
6.14
ROE
14.1%
Dividend yield
0.11%

As of 30-JUN-2026, promoters held 46.65% of Glenmark Pharmaceuticals (0.00 pp from 31-MAR-2026), foreign institutional investors 20.89%, domestic institutions 18.60%, the government 0.04% and the public 13.81%.

Glenmark Pharmaceuticals shareholding pattern

Percentage of shares held, by quarter, newest first.

Glenmark Pharmaceuticals shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202531-MAR-2025Change
Promoters46.65%46.65%46.65%46.65%46.65%n/a0.00 pp
Foreign institutions (FII/FPI)20.89%20.34%19.20%20.73%20.62%n/a+0.55 pp
Domestic institutions (DII)18.60%19.29%20.09%18.61%17.64%n/a-0.69 pp
Government0.04%0.04%0.04%0.04%0.04%n/a0.00 pp
Public13.81%13.68%14.02%13.97%15.06%n/a+0.13 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

Glenmark Pharmaceuticals shareholding pattern — frequently asked questions

What is the promoter holding in Glenmark Pharmaceuticals?

Promoters held 46.65% of Glenmark Pharmaceuticals as of 30-JUN-2026, unchanged from 46.65% in 31-MAR-2026.

How much do FIIs hold in Glenmark Pharmaceuticals?

Foreign institutional investors held 20.89% of Glenmark Pharmaceuticals as of 30-JUN-2026, a change of +0.55 pp from the previous quarter.

How much do domestic institutions hold in Glenmark Pharmaceuticals?

Domestic institutional investors, including mutual funds and insurers, held 18.60% of Glenmark Pharmaceuticals as of 30-JUN-2026 (-0.69 pp from the previous quarter).

Who owns Glenmark Pharmaceuticals?

As of 30-JUN-2026, Glenmark Pharmaceuticals' shareholders were promoters (46.65%), foreign institutional investors 20.89%, domestic institutions 18.60%, the government 0.04% and the public 13.81%, as filed with the stock exchanges.

Same Data For Peers

💡 LearnHow to read a shareholding pattern →

Trade Glenmark Pharmaceuticals With ATS

Track GLENMARK live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Glenmark Pharmaceuticals share priceOpen a demat account →Brokerage calculator

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.